Z ) 4, T ) -180 °C, µ(Mo KR) ) 0.231 mm-1, Dcalcd
)
TABLE 2. Reaction of 3c with Secondary Amines
1.426 g‚cm-3, 2θmax 55° (CCD area detector, Mo KR radiation),
GOF ) 0.96, wR(F2) ) 0.087 (all 1044 data), R ) 0.030 (936 data
with I > 2σI).
(E)-N-(2-(Piperidin-1-yldiazenyl)phenyl)piperidine-1-sulfona-
mide (2b): white crystal (53%); mp 74-76 °C (hexanes/dichlo-
1
romethane); H NMR (CDCl3) δ 7.73 (br s, 1H), 7.54 (d, J )
8.0 Hz, 1H), 7.46 (d, J ) 7.8 Hz, 1H), 7.10 (t, J ) 7.3 Hz, 1H),
7.02 (t, J ) 7.4 Hz, 1H), 3.80 (br s, 4H), 3.26-3.10 (m, 4H), 1.73
(br s, 6H), 1.58-1.34 (m, 6H); 13C NMR (CDCl3) δ 138.4, 132.1,
126.1, 123.7, 119.1, 116.2, 47.0, 25.2, 24.1, 23.5. Anal. Calcd for
C16H25N5O2S: C, 54.68; H, 7.17; N, 19.93. Found: C, 54.64; H,
7.26; N, 19.75.
(E)-N-(2-(Morpholinodiazenyl)phenyl)morpholine-4-sulfona-
mide (2c): white crystal (63%); mp 123-125 °C (hexanes/
1
dichloromethane); H NMR (CDCl3) δ 7.70 (br s, 1H), 7.57 (d, J
) 8.2 Hz, 1H), 7.49 (d, J ) 8.1 Hz, 1H), 7.17 (t, J ) 7.4 Hz, 1H),
7.07 (t, J ) 7.7 Hz, 1H), 3.88 (d, J ) 4.8 Hz, 4H), 3.82 (d, J ) 4.7
Hz, 4H), 3.62 (t, J ) 4.0 Hz, 4H), 3.21 (t, J ) 4.3 Hz, 4H); 13C
NMR (CDCl3) δ 137.9, 132.0, 127.1, 124.2, 119.4, 116.9, 66.1,
46.3. Anal. Calcd for C14H21N5O4S: C, 47.31; H, 5.96; N, 19.70.
Found: C, 47.57; H, 5.99; N, 19.67.
(E)-N-(2-(Diethylamino-1-yldiazenyl)phenyl)diethylamine-1-
sulfonamide (2d): white crystal (75%); mp 54-56 °C (hexanes/
1
dichloromethane); H NMR (CDCl3) δ 7.82 (br s, 1H), 7.46 (t, J
) 8.0 Hz, 2H), 7.08 (t, J ) 7.2 Hz, 1H), 7.00 (t, J ) 7.2 Hz, 1H),
3.78 (q, J ) 6.3 Hz, 4H), 3.26 (q, J ) 7.0 Hz, 4H), 1.28 (br s, 6H),
1.05 (t, J ) 7.0 Hz, 6H); 13C NMR (CDCl3) δ 138.8, 131.8, 125.6,
123.5, 118.6, 116.2, 42.0, 13.5. Anal. Calcd for C14H25N5O2S: C,
51.35; H, 7.70; N, 21.39. Found: C, 51.51; H, 7.78; N, 21.30.
1-(Piperidine-1-sulfonyl)-1H-benzotriazole (3b): white crystal
(10%); mp 50-52 °C (hexanes); 1H NMR (CDCl3) δ 8.12 (d, J )
8.3 Hz, 1H), 8.79 (d, J ) 8.3 Hz, 1H), 7.63 (t, J ) 8.1 Hz, 1H),
7.48 (t, J ) 8.1 Hz, 1H), 3.43 (t, J ) 5.4 Hz, 4H), 1.55 (m, 6H);
13C NMR (CDCl3) δ 144.8, 132.5, 129.7, 125.4, 120.2, 112.2, 48.1,
24.8, 23.0. Anal. Calcd for C11H14N4O2S: C, 49.61; H, 5.30; N,
21.04. Found: C, 49.66; H, 5.27; N, 21.02.
1-(Morpholine-4-sulfonyl)-1H-benzotriazole (3c): white crystal
(14%); mp 135-137 °C (hexanes); 1H NMR (CDCl3) δ 8.15 (d, J
) 8.4 Hz, 1H), 7.97 (d, J ) 8.4 Hz, 1H), 7.65 (t, J ) 8.1 Hz, 1H),
7.51 (t, J ) 8.1 Hz, 1H), 3.77 (t, J ) 4.8 Hz, 4H), 3.44 (t, J )
4.8 Hz, 4H); 13C NMR (CDCl3) δ 144.7, 132.5, 130.1, 125.6, 120.4,
111.9, 65.7, 46.9. Anal. Calcd for C10H12N4O3S: C, 44.77; H, 4.51;
N, 20.88. Found: C, 45.14; H, 4.44; N, 20.81.
a Isolated yields of pure products.
(Table 2). Products 4a-c were purified by flash column chro-
matography, using silica gel and a mixture of hexanes and ethyl
acetate as the eluent, and characterized by their spectral properties.
In summary, the reaction of Bt2SO2 (1) with secondary amines
at room temperature provides the first entry to novel o-
sulfamidotriazobenzenes 2 in good yields by a convenient
straightforward one-step method. Byproduct N-sulfonylbenzo-
triazoles 3 enable the preparation of unsymmetrical sulfamides
4 in high yields.
Benzotriazole-1-sulfonic acid N-methyl N-phenylamide (3e):
pink crystal (70%); mp 74-76 °C (hexanes); 1H NMR (CDCl3) δ
8.10 (d, J ) 8.3 Hz, 1H), 7.53 (d, J ) 8.3 Hz, 1H), 7.41-7.44 (m,
2H), 7.25-7.28 (m, 3H), 7.11-7.08 (m, 2H), 3.59 (s, 3H);
13C NMR (CDCl3) δ 144.6, 139.3, 132.8, 129.7, 129.5, 128.9, 127.0,
125.4, 120.1, 112.1, 40.8. Anal. Calcd for C13H12N4O2S: C, 54.15;
H, 4.19; N, 19.43. Found: C, 54.07; H, 4.06; N, 19.81.
Benzotriazole-1-sulfonic acid N,N-di-p-tolylamide (3f): white
needles (73%); mp 125-127 °C (hexanes); 1H NMR (CDCl3)
δ 8.02 (dd, J ) 7.4, 1.6 Hz, 1H), 7.53 (dd, J ) 7.4, 1.5 Hz, 1H),
7.39 (td, J ) 7.0, 1.2 Hz, 2H), 7.34 (td, J ) 7.0, 1.2 Hz, 2H), 7.22
(d, J ) 8.4 Hz, 4H), 7.02 (d, J ) 8.4 Hz, 4H), 2.20 (s, 6H);
13C NMR (CDCl3) δ 144.7, 138.8, 137.4, 132.7, 130.2, 129.6, 127.9,
125.3, 120.0, 112.4, 21.0; HRMS-FAB m/z [M + Na]+ calcd for
C20H18N4O2SNa 401.1043, found 401.1053.
Experimental Section
1,1′-Sulfonylbis(benzotriazole) (1) was prepared by a slight
modification of a previously published procedure.16
General Procedure for the Preparation of 2a-d and 3b,c,e.
To 1,1-sulfonylbenzotriazole (1 g, 3.3 mmol) in anhydrous aceto-
nitrile (15 mL) was added dropwise amine (9.9 mmol, 3 equiv)
with stirring at rt for 5 h. The mixture after removal of the solvent
was subjected to column chromatography (5-20% ethyl acetate in
hexanes) to give pure products 2a-d and 3b,c,e,f.
(E)-N-(2-(Pyrrolidin-1-yldiazenyl)phenyl)pyrrolidine-1-sul-
fonamide (2a): white crystals (55%); mp 109-111 °C (hexanes/
dichloromethane); 1H NMR (CDCl3) δ 7.81 (s, 1H), 7.57 (dd, J )
8.0, 1.4 Hz, 1H), 7.43 (dd, J ) 7.8, 1.4 Hz, 1H), 7.08 (td, J ) 7.4,
1.5 Hz, 1H), 7.01 (td, J ) 7.8, 1.5 Hz, 1H), 3.95 (br s, 2H), 3.63
(br s, 2H), 3.29 (t, J ) 6.9 Hz, 4H), 2.06 (br s, 4H), 1.75-1.69 (m,
4H); 13C NMR (CDCl3) δ 139.1, 131.8, 125.6, 123.8, 119.1, 115.8,
48.3, 25.6. Anal. Calcd for C14H21N5O2S: C, 51.99; H, 6.54; N,
21.65. Found: C, 52.16; H, 6.58; N, 21.44.
Acknowledgment. We thank William Lewis for assistance
with the X-ray crystallography.
Crystal data for 2a: C14H21N5O2S, MW 323.42, monoclinic,
space group P21/c, a ) 10.1479(3) Å, b ) 10.2295(3) Å, c )
14.7132(4) Å, â ) 99.468(1)°, V ) 1506.54(7) Å,3 F(000) ) 688,
Supporting Information Available: Characterization data and
details for the crystal structure of 1 and 2a. This material is available
(27) Ciba, Ltd., Patent BE 621190; Chem. Abstr. 1963, 59, 62444.
5808 J. Org. Chem., Vol. 72, No. 15, 2007
JO0705723